Risk Sciences International (RSI) is proud to announce that CEO Greg Paoli has been designated as a Fellow of the Society for Risk Analysis (SRA). SRA President Jacqueline MacDonald-Gibson presented the Fellowship during the Awards Luncheon at the Society’s Annual Meeting this past December in Washington, DC.
The status of Fellow is one of the highest honors in the field. The award citation designates Paoli as a Fellow “in recognition of outstanding contributions to the profession of Risk Analysis.”
While acknowledging the personal honor, Paoli emphasized the collaborative nature of risk science. “It’s true that I have been active in risk science for decades now,” Paoli noted, “but it is also true that much of my success has come from the support and teachings of both my amazing co-workers and our diverse range of clients.”
This designation marks a significant milestone in RSI’s continued leadership in the field. It represents the fifth major award bestowed upon RSI personnel by the SRA:
- Daniel Krewski: Fellow (1993)
- Greg Paoli: Distinguished Lectureship Award (2009)
- Daniel Krewski: Distinguished Achievement Award (2013)
- Emma Harnett: Chauncey Starr Award (2016)
- Greg Paoli: Fellow (2025)
Relevant links
-
Link to SRA News Release 9 Dec 2025:
https://www.sra.org/2025/12/09/ten-honored-by-society-for-risk-analysis-2/
Experts related to this news item
More RSI News
IAI climate change report
The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…
Quinolones and risk of acute liver failure
Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…
RSI launches Global Risk Census
Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be…
US FDA FAERS and quinolones
Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…